SCHEMBL30493526

SCHEMBL30493526

CC(O)c1nc2ccc(Br)cc2[nH]c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
RAB9A P51151 1/20 0.51
HTT P42858 1/20 0.51
EGFR P00533 1/20 0.50
ALDH1A1 P00352 3/20 0.48
TYMS P04818 2/20 0.46
MMP2 P08253 3/20 0.44
MMP9 P14780 3/20 0.44
MMP8 P22894 3/20 0.44
MMP13 P45452 3/20 0.44
CYP1A2 P05177 2/20 0.43
EGLN1 Q9GZT9 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALOX15 P16050 1/20 0.41
AURKA O14965 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25317041 1.00 LMNA (0.51) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL29397532 0.77 HTT (0.56) LMNAHTTALDH1A1MMP2MMP9
SCHEMBL22963743 0.77 HTT (0.56) LMNAHTTALDH1A1MMP2MMP9
SCHEMBL14474322 0.76 ALDH1A1 (0.54) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL25317192 0.75 EGFR (0.54) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL30493647 0.75 EGFR (0.54) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL1544619 0.73 PLAUR (0.59) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL25318611 0.73 KDM4E (0.62) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL30493540 0.73 KDM4E (0.62) LMNARAB9AHTTEGFRALDH1A1
SCHEMBL24157376 0.71 TYMS (0.33) HTTALDH1A1TYMSCYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116425744-A Piperazine-containing ring derivative, pharmaceutically acceptable salt thereof, and preparation method and application thereof 优领医药科技(香港)有限公司 2023-07-14 CN disclosed